Natural history of facioscapulohumeral muscular dystrophy evaluated by multiparametric quantitative MRI: a prospective cohort study
Background Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic resonance imaging (MRI) studies demonstrated that the risk of developing irreversible fatty replacement is higher in muscles showing edema...
Saved in:
Published in | Journal of neurology Vol. 272; no. 4; p. 306 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.04.2025
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic resonance imaging (MRI) studies demonstrated that the risk of developing irreversible fatty replacement is higher in muscles showing edematous lesions. The quantification of this phenomenon is an understudied topic in FSHD and intramuscular water content can also represent a potential biomarker sensitive to the effect of investigational drugs. We applied a multiparametric quantitative muscle MRI protocol to assess disease progression quantifying fatty replacement and muscle edema over 2 years, using fat fraction (FF) and water-T2 (wT2) metrics.
Methods
Thirty FSHD patients with at least one muscle showing signs of edema on conventional MRI were enrolled. FF and wT2 maps were assessed in 12 thigh and 6 leg muscles for each side, and a linear mixed model was employed to explore their variations over time. The measurements were acquired at baseline, 12, and 24 months. Quantitative MRI parameters were also correlated with clinical scales and functional assessments collected at baseline.
Results
The average yearly increase in FF was 2 ± 0.6% at thigh level and 1.9 ± 0.7% at leg level. No significant longitudinal changes in wT2 were observed. Muscles with intermediate FF (15–30%) at baseline and those with baseline wT2 values above 41 ms showed the highest increase in fat replacement. Both FF and wT2 showed significant correlations with clinical scales and functional assessments.
Conclusions
Our longitudinal study identified muscles and compartments more likely to show FF increase in FSHD subjects. Multiparametric quantitative MRI metrics should be incorporated into clinical trial frameworks to explore their potential in detecting early therapeutic effects. |
---|---|
AbstractList | Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic resonance imaging (MRI) studies demonstrated that the risk of developing irreversible fatty replacement is higher in muscles showing edematous lesions. The quantification of this phenomenon is an understudied topic in FSHD and intramuscular water content can also represent a potential biomarker sensitive to the effect of investigational drugs. We applied a multiparametric quantitative muscle MRI protocol to assess disease progression quantifying fatty replacement and muscle edema over 2 years, using fat fraction (FF) and water-T2 (wT2) metrics.BACKGROUNDFacioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic resonance imaging (MRI) studies demonstrated that the risk of developing irreversible fatty replacement is higher in muscles showing edematous lesions. The quantification of this phenomenon is an understudied topic in FSHD and intramuscular water content can also represent a potential biomarker sensitive to the effect of investigational drugs. We applied a multiparametric quantitative muscle MRI protocol to assess disease progression quantifying fatty replacement and muscle edema over 2 years, using fat fraction (FF) and water-T2 (wT2) metrics.Thirty FSHD patients with at least one muscle showing signs of edema on conventional MRI were enrolled. FF and wT2 maps were assessed in 12 thigh and 6 leg muscles for each side, and a linear mixed model was employed to explore their variations over time. The measurements were acquired at baseline, 12, and 24 months. Quantitative MRI parameters were also correlated with clinical scales and functional assessments collected at baseline.METHODSThirty FSHD patients with at least one muscle showing signs of edema on conventional MRI were enrolled. FF and wT2 maps were assessed in 12 thigh and 6 leg muscles for each side, and a linear mixed model was employed to explore their variations over time. The measurements were acquired at baseline, 12, and 24 months. Quantitative MRI parameters were also correlated with clinical scales and functional assessments collected at baseline.The average yearly increase in FF was 2 ± 0.6% at thigh level and 1.9 ± 0.7% at leg level. No significant longitudinal changes in wT2 were observed. Muscles with intermediate FF (15-30%) at baseline and those with baseline wT2 values above 41 ms showed the highest increase in fat replacement. Both FF and wT2 showed significant correlations with clinical scales and functional assessments.RESULTSThe average yearly increase in FF was 2 ± 0.6% at thigh level and 1.9 ± 0.7% at leg level. No significant longitudinal changes in wT2 were observed. Muscles with intermediate FF (15-30%) at baseline and those with baseline wT2 values above 41 ms showed the highest increase in fat replacement. Both FF and wT2 showed significant correlations with clinical scales and functional assessments.Our longitudinal study identified muscles and compartments more likely to show FF increase in FSHD subjects. Multiparametric quantitative MRI metrics should be incorporated into clinical trial frameworks to explore their potential in detecting early therapeutic effects.CONCLUSIONSOur longitudinal study identified muscles and compartments more likely to show FF increase in FSHD subjects. Multiparametric quantitative MRI metrics should be incorporated into clinical trial frameworks to explore their potential in detecting early therapeutic effects. Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic resonance imaging (MRI) studies demonstrated that the risk of developing irreversible fatty replacement is higher in muscles showing edematous lesions. The quantification of this phenomenon is an understudied topic in FSHD and intramuscular water content can also represent a potential biomarker sensitive to the effect of investigational drugs. We applied a multiparametric quantitative muscle MRI protocol to assess disease progression quantifying fatty replacement and muscle edema over 2 years, using fat fraction (FF) and water-T2 (wT2) metrics. Thirty FSHD patients with at least one muscle showing signs of edema on conventional MRI were enrolled. FF and wT2 maps were assessed in 12 thigh and 6 leg muscles for each side, and a linear mixed model was employed to explore their variations over time. The measurements were acquired at baseline, 12, and 24 months. Quantitative MRI parameters were also correlated with clinical scales and functional assessments collected at baseline. The average yearly increase in FF was 2 ± 0.6% at thigh level and 1.9 ± 0.7% at leg level. No significant longitudinal changes in wT2 were observed. Muscles with intermediate FF (15-30%) at baseline and those with baseline wT2 values above 41 ms showed the highest increase in fat replacement. Both FF and wT2 showed significant correlations with clinical scales and functional assessments. Our longitudinal study identified muscles and compartments more likely to show FF increase in FSHD subjects. Multiparametric quantitative MRI metrics should be incorporated into clinical trial frameworks to explore their potential in detecting early therapeutic effects. Background Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic resonance imaging (MRI) studies demonstrated that the risk of developing irreversible fatty replacement is higher in muscles showing edematous lesions. The quantification of this phenomenon is an understudied topic in FSHD and intramuscular water content can also represent a potential biomarker sensitive to the effect of investigational drugs. We applied a multiparametric quantitative muscle MRI protocol to assess disease progression quantifying fatty replacement and muscle edema over 2 years, using fat fraction (FF) and water-T2 (wT2) metrics. Methods Thirty FSHD patients with at least one muscle showing signs of edema on conventional MRI were enrolled. FF and wT2 maps were assessed in 12 thigh and 6 leg muscles for each side, and a linear mixed model was employed to explore their variations over time. The measurements were acquired at baseline, 12, and 24 months. Quantitative MRI parameters were also correlated with clinical scales and functional assessments collected at baseline. Results The average yearly increase in FF was 2 ± 0.6% at thigh level and 1.9 ± 0.7% at leg level. No significant longitudinal changes in wT2 were observed. Muscles with intermediate FF (15–30%) at baseline and those with baseline wT2 values above 41 ms showed the highest increase in fat replacement. Both FF and wT2 showed significant correlations with clinical scales and functional assessments. Conclusions Our longitudinal study identified muscles and compartments more likely to show FF increase in FSHD subjects. Multiparametric quantitative MRI metrics should be incorporated into clinical trial frameworks to explore their potential in detecting early therapeutic effects. BackgroundFacioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic resonance imaging (MRI) studies demonstrated that the risk of developing irreversible fatty replacement is higher in muscles showing edematous lesions. The quantification of this phenomenon is an understudied topic in FSHD and intramuscular water content can also represent a potential biomarker sensitive to the effect of investigational drugs. We applied a multiparametric quantitative muscle MRI protocol to assess disease progression quantifying fatty replacement and muscle edema over 2 years, using fat fraction (FF) and water-T2 (wT2) metrics.MethodsThirty FSHD patients with at least one muscle showing signs of edema on conventional MRI were enrolled. FF and wT2 maps were assessed in 12 thigh and 6 leg muscles for each side, and a linear mixed model was employed to explore their variations over time. The measurements were acquired at baseline, 12, and 24 months. Quantitative MRI parameters were also correlated with clinical scales and functional assessments collected at baseline.ResultsThe average yearly increase in FF was 2 ± 0.6% at thigh level and 1.9 ± 0.7% at leg level. No significant longitudinal changes in wT2 were observed. Muscles with intermediate FF (15–30%) at baseline and those with baseline wT2 values above 41 ms showed the highest increase in fat replacement. Both FF and wT2 showed significant correlations with clinical scales and functional assessments.ConclusionsOur longitudinal study identified muscles and compartments more likely to show FF increase in FSHD subjects. Multiparametric quantitative MRI metrics should be incorporated into clinical trial frameworks to explore their potential in detecting early therapeutic effects. |
ArticleNumber | 306 |
Author | Torchia, E. Pichiecchio, A. Ravera, B. Santini, F. Barzaghi, L. Monforte, M. Figini, S. Tasca, G. Manco, G. Ricci, E. Faggioli, A. Tartaglione, T. Bortolani, S. Deligianni, X. Bergsland, N. Paoletti, M. Solazzo, F. Ballante, E. |
Author_xml | – sequence: 1 givenname: M. surname: Paoletti fullname: Paoletti, M. organization: Advanced Imaging and Artificial Intelligence, Neuroradiology Department, IRCCS Mondino Foundation – sequence: 2 givenname: M. orcidid: 0000-0002-4327-6969 surname: Monforte fullname: Monforte, M. email: mauro.monforte@policlinicogemelli.it organization: Dipartimento di Neuroscienze, Organi di Senso e Torace, UOC di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS – sequence: 3 givenname: L. surname: Barzaghi fullname: Barzaghi, L. organization: Advanced Imaging and Artificial Intelligence, Neuroradiology Department, IRCCS Mondino Foundation, INFN, Group of Pavia, Department of Mathematics, University of Pavia – sequence: 4 givenname: G. surname: Tasca fullname: Tasca, G. organization: John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trusts – sequence: 5 givenname: N. surname: Bergsland fullname: Bergsland, N. organization: Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, Buffalo Neuroimaging Analysis Center, University of Buffalo, the State University of New York, IRCCS, Fondazione Don Carlo Gnocchi ONLUS – sequence: 6 givenname: A. surname: Faggioli fullname: Faggioli, A. organization: Advanced Imaging and Artificial Intelligence, Neuroradiology Department, IRCCS Mondino Foundation – sequence: 7 givenname: F. surname: Solazzo fullname: Solazzo, F. organization: Advanced Imaging and Artificial Intelligence, Neuroradiology Department, IRCCS Mondino Foundation – sequence: 8 givenname: G. surname: Manco fullname: Manco, G. organization: Advanced Imaging and Artificial Intelligence, Neuroradiology Department, IRCCS Mondino Foundation – sequence: 9 givenname: S. surname: Bortolani fullname: Bortolani, S. organization: Dipartimento di Neuroscienze, Organi di Senso e Torace, UOC di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS – sequence: 10 givenname: E. surname: Torchia fullname: Torchia, E. organization: Università Cattolica del Sacro Cuore – sequence: 11 givenname: B. surname: Ravera fullname: Ravera, B. organization: Università Cattolica del Sacro Cuore – sequence: 12 givenname: X. surname: Deligianni fullname: Deligianni, X. organization: Department of Radiology, University Hospital Basel, Department of Biomedical Engineering, Basel Muscle MRI, University of Basel – sequence: 13 givenname: F. surname: Santini fullname: Santini, F. organization: Department of Radiology, University Hospital Basel, Department of Biomedical Engineering, Basel Muscle MRI, University of Basel – sequence: 14 givenname: E. surname: Ballante fullname: Ballante, E. organization: Department of Political and Social Sciences, University of Pavia, BioData Science Center, IRCCS Mondino Foundation – sequence: 15 givenname: S. surname: Figini fullname: Figini, S. organization: Department of Political and Social Sciences, University of Pavia, BioData Science Center, IRCCS Mondino Foundation – sequence: 16 givenname: T. surname: Tartaglione fullname: Tartaglione, T. organization: Università Cattolica del Sacro Cuore, Istituto Dermopatico Dell’Immacolata (IDI), IRCCS – sequence: 17 givenname: E. surname: Ricci fullname: Ricci, E. organization: Dipartimento di Neuroscienze, Organi di Senso e Torace, UOC di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore – sequence: 18 givenname: A. surname: Pichiecchio fullname: Pichiecchio, A. organization: Advanced Imaging and Artificial Intelligence, Neuroradiology Department, IRCCS Mondino Foundation, Department of Brain and Behavioural Sciences, University of Pavia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40172709$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktv1DAUhS1URKeFP8ACWWLDJuBHHDtsEKooVCogIVhbd2ynSZXEqR8jZc0frztTymPBypbPd67vtc8JOpr97BB6TslrSoh8EwmpqagIExXlpGGVeoQ2tOasorVoj9CG8JpUgov6GJ3EeE0IUUV4go5rQiWTpN2gn18g5QAj7oeYfFix73AHZvDRwJJH3-fJ3clTjiaPELBdYwp-6VfsdjBmSM7i7Vr0MQ0LBJhcCoPBNxnmNCRIw87hz98u3mLAS_BxcWZ_ZHzvQ8IxZbs-RY87GKN7dr-eoh_nH76ffaouv368OHt_WZmaqVQZyVvpHHRWMihbxu1WdS2VlklVW8m5taITyjRWkRYs441UxChQYFXTOH6K3h3qLnk7OWvcnMpoegnDBGHVHgb9tzIPvb7yO01p2wjWsFLh1X2F4G-yi0lPQzRuHGF2PkfNqRKMCtG0BX35D3rtc5jLfHtKEEEIL9SLP1t66OXXBxWAHQBTHi8G1z0glOi7FOhDCnRJgd6nQKti4gdTLPB85cLvu__jugWD47hz |
Cites_doi | 10.1016/j.nmd.2019.08.011 10.1002/jcsm.12555 10.1007/s12035-017-0563-x 10.1002/ana.24640 10.1002/jcsm.13250 10.3389/fneur.2021.630387 10.1002/jmri.24619 10.3389/fneur.2021.749736 10.1093/hmg/ddaa031 10.1007/s10334-021-00967-4 10.1212/WNL.0000000000010155 10.48550/arXiv.2302.06352 10.1002/mus.23911 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M 10.1212/WNL.0000000000200757 10.1038/s43856-022-00217-1 10.1038/s41598-024-65802-x 10.1016/j.nmd.2022.10.005 10.1371/journal.pone.0038779 10.1007/s00415-022-11336-z 10.1371/journal.pone.0183825 10.1002/jcsm.12343 10.3389/fneur.2019.00078 10.1109/EMBC.2016.7591443 10.1007/s00415-016-8361-3 10.1007/s00415-021-10786-1 10.1212/CON.0000000000001155 10.1186/s12891-021-04134-7 10.1007/s00330-020-07487-0 10.1016/j.nmd.2025.105274 10.3233/JND-240053 10.1007/s00415-019-09242-y 10.1097/WCO.0000000000001305 10.1093/hmg/ddy364 10.1212/WNL.0000000000004647 10.1002/jcsm.12473 10.1212/WNL.0000000000002640 10.1002/nbm.5214 10.3233/JND-160145 10.1002/jmri.24613 10.3389/fneur.2021.675781 |
ContentType | Journal Article |
Copyright | The Author(s) 2025 2025. The Author(s). Copyright Springer Nature B.V. Apr 2025 The Author(s) 2025 2025 |
Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: Copyright Springer Nature B.V. Apr 2025 – notice: The Author(s) 2025 2025 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK K9. 7X8 5PM |
DOI | 10.1007/s00415-025-13062-8 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1432-1459 |
ExternalDocumentID | PMC11965262 40172709 10_1007_s00415_025_13062_8 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Ministero della Salute grantid: RF-2016-02362914 funderid: http://dx.doi.org/10.13039/501100003196 – fundername: Università Cattolica del Sacro Cuore – fundername: Ministero della Salute grantid: RF-2016-02362914 |
GroupedDBID | --- -Y2 .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 2.D 203 28- 29L 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3SX 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHIR ADHKG ADIMF ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDYV AFDZB AFEXP AFFNX AFJLC AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHPBZ AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD AYFIA AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI C6C CAG CCPQU COF CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PHGZT PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 X7M YLTOR Z45 ZGI ZMTXR ZOVNA ZXP ~EX ~KM AAYXX ABFSG ACSTC AEZWR AFHIU AFOHR AHWEU AIXLP ATHPR CITATION PHGZM ABRTQ CGR CUY CVF ECM EIF NPM 7TK K9. 7X8 5PM |
ID | FETCH-LOGICAL-c428t-c7397eeafd72a39723db8f917d2784d733dd5f58c6d809ad236780c8a8ad866e3 |
IEDL.DBID | U2A |
ISSN | 0340-5354 1432-1459 |
IngestDate | Thu Aug 21 18:37:50 EDT 2025 Fri Jul 11 18:50:54 EDT 2025 Fri Jul 25 22:46:24 EDT 2025 Mon Jul 21 05:41:54 EDT 2025 Sun Jul 06 05:09:04 EDT 2025 Sat Apr 19 01:11:19 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Fat fraction WT2 QMRI Imaging FSHD Muscle Quantitative MRI |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c428t-c7397eeafd72a39723db8f917d2784d733dd5f58c6d809ad236780c8a8ad866e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-4327-6969 |
OpenAccessLink | https://link.springer.com/10.1007/s00415-025-13062-8 |
PMID | 40172709 |
PQID | 3185505003 |
PQPubID | 47196 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11965262 proquest_miscellaneous_3185215569 proquest_journals_3185505003 pubmed_primary_40172709 crossref_primary_10_1007_s00415_025_13062_8 springer_journals_10_1007_s00415_025_13062_8 |
PublicationCentury | 2000 |
PublicationDate | 2025-04-01 |
PublicationDateYYYYMMDD | 2025-04-01 |
PublicationDate_xml | – month: 04 year: 2025 text: 2025-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
PublicationTitle | Journal of neurology |
PublicationTitleAbbrev | J Neurol |
PublicationTitleAlternate | J Neurol |
PublicationYear | 2025 |
Publisher | Springer Berlin Heidelberg Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
References | JW Chardon (13062_CR3) 2019; 29 SCC Vincenten (13062_CR18) 2023; 14 M Paoletti (13062_CR40) 2021; 12 M Monforte (13062_CR13) 2019; 10 F Santini (13062_CR28) 2021; 12 C Nuñez-Peralta (13062_CR29) 2020; 11 H Reyngoudt (13062_CR34) 2021; 31 M Weigel (13062_CR27) 2015; 41 A Alonso-Jiménez (13062_CR33) 2021; 12 ML Mellion (13062_CR20) 2022; 99 PA Yushkevich (13062_CR25) 2016; 2016 G Tasca (13062_CR12) 2016; 79 JR Dahlqvist (13062_CR37) 2019; 266 JR Dahlqvist (13062_CR19) 2020; 95 A Agosti (13062_CR23) 2021; 35 E Vegezzi (13062_CR39) 2023; 270 PG Carlier (13062_CR5) 2016; 3 L Heskamp (13062_CR35) 2022; 2 13062_CR24 C Bolano-Díaz (13062_CR2) 2024; 37 N Azzabou (13062_CR30) 2015; 41 J Forsting (13062_CR41) 2024; 37 M Monforte (13062_CR31) 2021; 269 SCC Vincenten (13062_CR36) 2025; 47 M Paoletti (13062_CR6) 2019; 10 SD Friedman (13062_CR11) 2014; 49 G Tasca (13062_CR8) 2012; 7 K Mul (13062_CR1) 2022; 28 B Janssen (13062_CR15) 2016; 86 F Fatehi (13062_CR17) 2017; 12 13062_CR26 L Schlaffke (13062_CR38) 2024; 11 K Mul (13062_CR21) 2017; 89 L Riem (13062_CR32) 2024; 14 LH Wang (13062_CR16) 2021; 22 M Monforte (13062_CR4) 2022; 33 C-J Wong (13062_CR7) 2020; 29 G Tasca (13062_CR10) 2018; 55 A Grimm (13062_CR42) 2018; 9 LH Wang (13062_CR9) 2019; 28 G Andersen (13062_CR14) 2017; 264 E Ricci (13062_CR22) 1999; 45 |
References_xml | – volume: 29 start-page: 827 year: 2019 ident: 13062_CR3 publication-title: Neuromuscul Disord doi: 10.1016/j.nmd.2019.08.011 – volume: 11 start-page: 1032 year: 2020 ident: 13062_CR29 publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12555 – volume: 55 start-page: 2959 year: 2018 ident: 13062_CR10 publication-title: Mol Neurobiol doi: 10.1007/s12035-017-0563-x – volume: 79 start-page: 854 year: 2016 ident: 13062_CR12 publication-title: Ann Neurol doi: 10.1002/ana.24640 – volume: 14 start-page: 1695 year: 2023 ident: 13062_CR18 publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.13250 – volume: 12 year: 2021 ident: 13062_CR28 publication-title: Front Neurol doi: 10.3389/fneur.2021.630387 – ident: 13062_CR26 – volume: 41 start-page: 266 year: 2015 ident: 13062_CR27 publication-title: J Magn Reson Imaging JMRI doi: 10.1002/jmri.24619 – volume: 12 year: 2021 ident: 13062_CR40 publication-title: Front Neurol doi: 10.3389/fneur.2021.749736 – volume: 29 start-page: 1030 year: 2020 ident: 13062_CR7 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddaa031 – volume: 35 start-page: 467 year: 2021 ident: 13062_CR23 publication-title: Magn Reson Mater Phys Biol Med doi: 10.1007/s10334-021-00967-4 – volume: 95 start-page: e1211 year: 2020 ident: 13062_CR19 publication-title: Neurology doi: 10.1212/WNL.0000000000010155 – ident: 13062_CR24 doi: 10.48550/arXiv.2302.06352 – volume: 49 start-page: 257 year: 2014 ident: 13062_CR11 publication-title: Muscle Nerve doi: 10.1002/mus.23911 – volume: 45 start-page: 751 year: 1999 ident: 13062_CR22 publication-title: Ann Neurol doi: 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M – volume: 99 start-page: e877 year: 2022 ident: 13062_CR20 publication-title: Neurology doi: 10.1212/WNL.0000000000200757 – volume: 2 start-page: 155 year: 2022 ident: 13062_CR35 publication-title: Commun Med doi: 10.1038/s43856-022-00217-1 – volume: 14 start-page: 15462 year: 2024 ident: 13062_CR32 publication-title: Sci Rep doi: 10.1038/s41598-024-65802-x – volume: 33 start-page: 65 year: 2022 ident: 13062_CR4 publication-title: Neuromuscul Disord doi: 10.1016/j.nmd.2022.10.005 – volume: 7 year: 2012 ident: 13062_CR8 publication-title: PLoS ONE doi: 10.1371/journal.pone.0038779 – volume: 270 start-page: 328 year: 2023 ident: 13062_CR39 publication-title: J Neurol doi: 10.1007/s00415-022-11336-z – volume: 12 year: 2017 ident: 13062_CR17 publication-title: PLoS ONE doi: 10.1371/journal.pone.0183825 – volume: 9 start-page: 1093 year: 2018 ident: 13062_CR42 publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12343 – volume: 10 start-page: 78 year: 2019 ident: 13062_CR6 publication-title: Front Neurol doi: 10.3389/fneur.2019.00078 – volume: 2016 start-page: 3342 year: 2016 ident: 13062_CR25 publication-title: Conf Proc Annu Int Conf IEEE Eng Med Biol Soc IEEE Eng Med Biol Soc Annu Conf doi: 10.1109/EMBC.2016.7591443 – volume: 264 start-page: 438 year: 2017 ident: 13062_CR14 publication-title: J Neurol doi: 10.1007/s00415-016-8361-3 – volume: 269 start-page: 2055 year: 2021 ident: 13062_CR31 publication-title: J Neurol doi: 10.1007/s00415-021-10786-1 – volume: 28 start-page: 1735 year: 2022 ident: 13062_CR1 publication-title: Contin Minneap Minn doi: 10.1212/CON.0000000000001155 – volume: 22 start-page: 262 year: 2021 ident: 13062_CR16 publication-title: BMC Musculoskelet Disord doi: 10.1186/s12891-021-04134-7 – volume: 31 start-page: 4264 year: 2021 ident: 13062_CR34 publication-title: Eur Radiol doi: 10.1007/s00330-020-07487-0 – volume: 47 year: 2025 ident: 13062_CR36 publication-title: Neuromuscul Dis doi: 10.1016/j.nmd.2025.105274 – volume: 11 start-page: 997 year: 2024 ident: 13062_CR38 publication-title: J Neuromuscul Dis doi: 10.3233/JND-240053 – volume: 266 start-page: 1127 year: 2019 ident: 13062_CR37 publication-title: J Neurol doi: 10.1007/s00415-019-09242-y – volume: 37 start-page: 536 year: 2024 ident: 13062_CR2 publication-title: Curr Opin Neurol doi: 10.1097/WCO.0000000000001305 – volume: 28 start-page: 476 year: 2019 ident: 13062_CR9 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddy364 – volume: 89 start-page: 2057 year: 2017 ident: 13062_CR21 publication-title: Neurology doi: 10.1212/WNL.0000000000004647 – volume: 10 start-page: 1258 year: 2019 ident: 13062_CR13 publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12473 – volume: 86 start-page: 1700 year: 2016 ident: 13062_CR15 publication-title: Neurology doi: 10.1212/WNL.0000000000002640 – volume: 37 year: 2024 ident: 13062_CR41 publication-title: NMR Biomed doi: 10.1002/nbm.5214 – volume: 3 start-page: 1 year: 2016 ident: 13062_CR5 publication-title: J Neuromuscul Dis doi: 10.3233/JND-160145 – volume: 41 start-page: 645 year: 2015 ident: 13062_CR30 publication-title: J Magn Reson Imaging doi: 10.1002/jmri.24613 – volume: 12 year: 2021 ident: 13062_CR33 publication-title: Front Neurol doi: 10.3389/fneur.2021.675781 |
SSID | ssj0008459 |
Score | 2.4486027 |
Snippet | Background
Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle... Facioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle magnetic... BackgroundFacioscapulohumeral muscular dystrophy (FSHD) is a genetic disorder characterized by progressive skeletal muscle wasting. Longitudinal muscle... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 306 |
SubjectTerms | Adult Aged Cohort analysis Cohort Studies Disease Progression Edema Edema - diagnostic imaging Female Genetic disorders Humans Longitudinal Studies Magnetic Resonance Imaging Male Medicine Medicine & Public Health Middle Aged Multiparametric Magnetic Resonance Imaging - methods Muscle, Skeletal - diagnostic imaging Muscle, Skeletal - pathology Muscular dystrophy Muscular Dystrophy, Facioscapulohumeral - diagnostic imaging Muscular Dystrophy, Facioscapulohumeral - pathology Muscular Dystrophy, Facioscapulohumeral - physiopathology Neurology Neuroradiology Neurosciences Original Communication Prospective Studies Skeletal muscle Water content |
Title | Natural history of facioscapulohumeral muscular dystrophy evaluated by multiparametric quantitative MRI: a prospective cohort study |
URI | https://link.springer.com/article/10.1007/s00415-025-13062-8 https://www.ncbi.nlm.nih.gov/pubmed/40172709 https://www.proquest.com/docview/3185505003 https://www.proquest.com/docview/3185215569 https://pubmed.ncbi.nlm.nih.gov/PMC11965262 |
Volume | 272 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB7RVkJcEAUKgRJtpd6KJWcf9pZbGjUUUHJAjdSerMnuWq1U7JLYh5z548yuHygtHJAs-bAjr3dndjzjmfkG4JijROVSFQlSBOSguDxCbqVHwlRmpLXjAV1_Nk8uFvLrlbpqi8LWXbZ7F5IMmrovdvPQUL6aWEWkdxM6xzuwp7zvTlK84ONe_2oZWqTFQsaREkq2pTJ_f8b25-iRjfk4VfJBvDR8hqYv4HlrP7Jxw_B9eOKKl_B01kbIX8GvOQYkDdYACW9YmbMczW25Nnhf35U3dfgLxX7UTQYqs5t1tSpps1kL_O0sW25Yk2iIPnXLY_iznzUWoR6NtCObff_yiSGjdXSFmsw32l1VLKDVvobF9PxychG1jRYiQ95HFZmUrBLnMLcpR-H7kNmlzsmRsz4saVMhrFW50iaxOj5F61HfdGw0arQ6SZw4gN2iLNxbYGhHPBbC0eVkzi1qq4QxUmBK5PnpAE66_c7uGzyNrEdODtzJiDtZ4E6mB3DYsSRrz9Y68_XeZLeROhrAUT9Mp8KHOrBwZd3QkDGjEprwTcPBfjrp3d40phG9xduewCNub48UtzcBeXvk8Rd5wgfwsRODP-_172W8-z_y9_CMexEN-UGHsFutaveBTJ9qOYS98fTsbO7vn6-_nQ9hZ5JMhkH-fwMrsAKo |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB5RkNpeEPQBWx51pd7aSFk_EsMNrUDLY_dQgcQtmrUdgQQJ7CaHPfePd-xkgxbKASm3GcWxxx7PZGa-AfjJUaJyqYoEKQJyUFweIbfSI2Eq09fa8YCuPxonwyt5dq2uW5gcXwvzLH4fwD77voZYRaRtEzq972BNkqfs0_cGyaDTulqGxmixkHGkhJJtgcz_37F8Cb2wLF8mSD6LkobL52QD1lurkR01Yt6EFVd8gvejNi7-Gf6OMeBnsAY-eM7KnOVobsuZwYf6rrypw78ndl83eafMzmfVtKQlZi3ct7NsMmdNeiH6hC2P3M8eayxCFRrpRDb6c3rIkNE8FuWZzLfXnVYsYNR-gauT48vBMGrbK0SGfI4qMinZIs5hblOOwncfsxOdk_tmfTDSpkJYq3KlTWJ1fIDWY73p2GjUaHWSOPEVVouycNvA0PZ5LISjx8mcW9RWCWOkwJTY84Me_Fqsd_bQoGhkHV5ykE5G0smCdDLdg92FSLL2RM0yX-VN1hopoR786Mh0FnyAAwtX1g0PmTAqoQG3Ggl2w0nv7KYxUfSSbDsGj7O9TClubwLedt-jLvKE9-D3Yhs8fdfr0_j2Nvbv8GF4ObrILk7H5zvwkfvtGjKEdmG1mtZuj4yfarIfdv0_vlT9fg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BkSouiPLqQgtG4gZRs34kLrdqy6oFdoUQlXqLZv1QK0Gy7CaHPfPHGTsPWAoHpNw8imOPPZ7JzPcZ4BVHicrlKhFkCChAcT5BbmVgwlRmrLXjkV1_Ns_OLuT7S3X5G4o_Vrv3KckW0xBYmsr6aGn90QB8CzRRAVmsErLBGe3p23CHIpWYqJ1kk8EWaxmvS0uFTBMllOxgM39_x_bRdMPfvFk2-UfuNB5J0_twr_Ml2Umr_D245coHsDvrsuUP4cccI6sGa0mFN6zyzKO5rtYGl83X6qqJf6TYt6atRmV2s65XFU0860jAnWWLDWuLDjGUcQU-f_a9wTJi08hSstnn87cMGY2jB22ycOnuqmaRufYRXEzffZmcJd2lC4mhSKROTE4einPobc5RhDvJ7EJ7CupsSFHaXAhrlVfaZFanx2gDA5xOjUaNVmeZE49hp6xKtw8M7ZinQjh6nPTcorZKGCMF5iTuj0fwup_vYtlyaxQDi3LUTkHaKaJ2Cj2Cg14lRbfP1kXAfpMPR6ZpBC-HZtohIe2BpauaVoYcG5VRh09aDQ7dyRAC5ym16C3dDgKBfXu7pby-iizc48DFyDM-gjf9Mvj1Xf8extP_E38Bu59Op8XH8_mHZ3CXh9Uay4YOYKdeNe6QPKJ68Twu-p-b_gXU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Natural+history+of+facioscapulohumeral+muscular+dystrophy+evaluated+by+multiparametric+quantitative+MRI%3A+a+prospective+cohort+study&rft.jtitle=Journal+of+neurology&rft.au=Paoletti%2C+M&rft.au=Monforte%2C+M&rft.au=Barzaghi%2C+L&rft.au=Tasca%2C+G&rft.date=2025-04-01&rft.eissn=1432-1459&rft.volume=272&rft.issue=4&rft.spage=306&rft_id=info:doi/10.1007%2Fs00415-025-13062-8&rft_id=info%3Apmid%2F40172709&rft.externalDocID=40172709 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-5354&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-5354&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-5354&client=summon |